Skip to content

Nurse-Led Caregiver Support Program in Home Palliative Care

Effect of a Nurse-Led Caregiver Support Program on Caregiver Competency and Healthcare Utilization Among Family Caregivers in Home Palliative Care: A Randomized Controlled Trial

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07593729
Acronym
CARE-PAL
Enrollment
150
Registered
2026-05-18
Start date
2026-05-12
Completion date
2026-09-30
Last updated
2026-07-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Caregiver Burden, Home Care, Palliative Care

Keywords

Nurse-led intervention, Family caregiver, Caregiver competency, Home care, Randomized controlled trial, Palliative care, Healthcare utilization

Brief summary

This randomized controlled trial aims to evaluate the effect of a nurse-led caregiver support program on caregiver competency and healthcare utilization among family caregivers of patients receiving home palliative care. Family caregivers in the intervention group will receive a structured 6-week nurse-led support program including face-to-face education, weekly telephone coaching, caregiver guidance materials, and decision support for symptom management and healthcare utilization. The control group will continue to receive routine home palliative care services. Primary outcome is caregiver competency. Secondary outcomes include caregiver burden, self-efficacy, patient symptom burden, emergency department visits, and hospitalizations.

Detailed description

Palliative care aims to improve quality of life for individuals with life-threatening illnesses through symptom management and holistic care. In home palliative care settings, family caregivers play a critical role in providing daily care and symptom monitoring. However, caregiving responsibilities may lead to increased burden, stress, and inappropriate healthcare utilization. This study is designed as a single-center, parallel-group, randomized controlled trial to evaluate the effectiveness of a nurse-led caregiver support program among family caregivers of patients receiving home palliative care services. A total of 150 family caregivers will be recruited and randomized into intervention and control groups in a 1:1 ratio using computer-generated block randomization. Participants in the intervention group will receive a structured 6-week nurse-led caregiver support program consisting of an initial face-to-face educational session and weekly telephone coaching. Intervention content includes symptom management, daily care skills, medication management, complication recognition, caregiver self-care, stress management, and healthcare utilization decision support. Caregivers will also receive a caregiver guidebook and crisis management decision algorithm. Participants in the control group will continue receiving routine home palliative care services without additional structured support. Outcome assessments will be conducted at baseline (T0), post-intervention (T1), and 3-month follow-up (T2). The primary outcome is caregiver competency measured using the Care Competency Scale for Family Caregivers in Home Palliative Care. Secondary outcomes include caregiver burden, self-efficacy, patient symptom burden, emergency department visits, and hospitalizations. The study is expected to provide evidence regarding the effectiveness of nurse-led caregiver support interventions in home palliative care settings.

Interventions

BEHAVIORALNurse-Led Caregiver Support Program

Participants in the intervention group will receive a structured 6-week nurse-led caregiver support program including face-to-face education, weekly telephone coaching, caregiver guidance materials, symptom management support, medication management education, stress management strategies, and healthcare utilization decision support in addition to routine home palliative care services.

Sponsors

Kutahya Health Sciences University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
SINGLE (Outcomes Assessor)

Masking description

Outcome assessors and data analysts will be blinded to group allocation during data analysis.

Intervention model description

Participants will be randomized into intervention and control groups in a 1:1 ratio.

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Adult family caregivers of patients receiving home palliative care services * Age 18 years or older * Being the primary caregiver responsible for the patient's daily care * Ability to communicate in Turkish * Willingness to participate in the study

Exclusion criteria

* Professional or paid caregivers * Caregivers with severe cognitive impairment or severe psychiatric disorders * Inability to participate in follow-up assessments

Design outcomes

Primary

MeasureTime frameDescription
Care Competency Scale for Family Caregivers in Home Palliative CareBaseline, post-intervention at 6 weeks, and 3-month follow-upCaregiver competency will be assessed using the Care Competency Scale for Family Caregivers in Home Palliative Care. The scale includes 29 items scored on a 1-5 Likert scale. Total scores range from 29 to 145, with higher scores indicating greater caregiver competency.

Secondary

MeasureTime frameDescription
Zarit Burden InterviewBaseline, post-intervention at 6 weeks, and 3-month follow-upCaregiver burden will be assessed using the Zarit Burden Interview. Total scores range from 0 to 88, with higher scores indicating greater caregiver burden.
General Self-Efficacy ScaleBaseline, post-intervention at 6 weeks, and 3-month follow-upCaregiver self-efficacy will be assessed using the General Self-Efficacy Scale. Total scores range from 10 to 40, with higher scores indicating greater self-efficacy.
Integrated Palliative Care Outcome ScaleBaseline, post-intervention at 6 weeks, and 3-month follow-upPatient symptom burden will be assessed using the Integrated Palliative Care Outcome Scale proxy version. Total scores range from 0 to 68, with higher scores indicating greater symptom burden and unmet needs.
Emergency Department VisitsBaseline, post-intervention at 6 weeks, and 3-month follow-upEmergency department visits will be assessed as the number of emergency department visits during the follow-up period. Higher values indicate greater emergency healthcare utilization.
HospitalizationsDuring the 3-month follow-up periodHospitalizations will be assessed as the number of hospital admissions during the follow-up period. Higher values indicate greater inpatient healthcare utilization.

Countries

Turkey (Türkiye)

Contacts

CONTACTSerkan Budak, PhD / RN
serkan.budak@ksbu.edu.tr+905385430616

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jul 28, 2026